EQS-News: Biotest AG / Key word: Study
Biotest expands its clinical development program for trimodulin to patients with community-acquired pneumonia
12.12.2023 / 09:00.
EQS-News: Biotest AG / Key word(s): StudyBiotest expands its clinical development program for trimodulin to patients with community-acquired pneumonia (CAP) 12.12.2023 / 09:00 CET/CESTThe issuer is solely responsible for the content of this announcement. PRESS RELEASE Biotest expands its clinical d.
This newly developed prediction model evaluating community-acquired pneumonia risk was noted to demonstrate accuracy, strong discriminatory qualities, and practicability in clinical settings.
Alternative antibiotic selection can reduce the risk of health care-associated infections for patients with pneumonia medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
A new study on Clostridioides difficile infections finds that choosing an alternative antibiotic for high-risk patients with pneumonia can reduce infection risk.